Two Sigma Investments »

Neurosense Therapeutics shares owned by Two Sigma Investments

Quarter-by-quarter ownership of Neurosense Therapeutics (NRSN) shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in Neurosense Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neurosense Therapeutics held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurosense Therapeutics by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $26k 21k 1.25

More positions owned by Two Sigma Investments

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Select Sector Spdr Tr Financial (XLF)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Core S&p500 Etf (IVV)
Rivian Automotive Com Cl A (RIVN)
Palantir Technologies Cl A (PLTR)
NVIDIA Corporation (NVDA)
Micron Technology (MU)
Lockheed Martin Corporation (LMT)
Ishares Tr Rus 1000 Grw Etf (IWF)
Microsoft Corporation (MSFT)
Alnylam Pharmaceuticals (ALNY)

View all positions for Two Sigma Investments

Top funds holding Neurosense Therapeutics

Squarepoint Ops
Morgan Stanley
Meitav Dash Investments
Two Sigma Investments
Commonwealth Equity Services
Geode Capital Management
UBS Group
SBI Securities
Jones Financial Companies, L.L
CWM

View all funds holding Neurosense Therapeutics